Article Listing - Roche delays CERA US FDA filing, Amgen gains

STOCK MARKET COMMENTARY: EUROPE

13 April 1992

EUROPE: seemed to be impacted in many areas by elections of one sort or another. Despite earlier worries, FRANKFURT seemed...

CERVOXAN 60mg LAUNCHED IN FRANCE

13 April 1992

Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...

US RESISTANCE TO DRUG PRICE RISES

13 April 1992

The US pharmaceutical industry will continue to face growing resistance from the federal government and also from private forces towards...

EXPANSION AT SILESIA IN CHILE

13 April 1992

The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...

EPO AND HISTAMINE

13 April 1992

Recombinant erythropoietin therapy lowers plasma histamine concentrations in patients with uremia and can result in marked improvement of pruritus, according...

ROCHE'S LAZABEMIDE IN PHASE III NEXT YEAR

13 April 1992

Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...

SAFER TRAVELLER'S DIARRHEA DRUG

13 April 1992

A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...

ICN HUBBER GROUP IN SPAIN

6 April 1992

The ICN Hubber Group is investing 1.7 billion pesetas ($2.2 million) in a new pharmaceutical plant near Barcelona in Spain....

US FDA USER FEES: "THE TIME HAS COME"

6 April 1992

People in the US Food and Drug Administration-regulated industries now recognize that the time has arrived for user fees to...

WORLD MARKET FOR BIO-DRUGS

6 April 1992

Biopharmaceuticals will be the single fastest-growing segment of the total pharmaceutical market worldwide in the 1990s, with average annual growth...

Showing 94591-94600 of 95572 articles